FIELD: immunology.
SUBSTANCE: invention relates to immunology. To detect antitoxic IgG antibodies in quantitative terms (mcg/ml), a standard calibration sample containing 80 mcg/ml of anti-diphtheria antitoxic IgGs is put into the wells of a microplate with an occluded antigen (10 mcg/ml). The test samples of human blood serum are incubated. Then a conjugate of the horseradish peroxidase enzyme and rabbit antibodies against human IgGs are put into the wells at a dilution of 1: 16000. Incubation is carried out at a temperature of 37 ° C for 30 minutes in a thermal shaker with a frequency of 700 rpm. The contents of the wells are poured and washed four times with a phosphate buffered saline with Tween-20. After that a tetramethylbenzidine solution is added and incubated. A stop reagent is added to all wells of the plate and the formed immune complexes are detected at a wavelength of 450 nm. Calculation of the concentration of the determined antitoxic IgGs is carried out using a standard calibration sample with a known concentration of antitoxic IgGs taking into account the dilution of the samples. The kit for the determination of antitoxic anti-diphtheria antibodies of a person contains: a flat-bottomed microplate with the occluded antigen (10 mcg/ml), a standard calibration sample containing anti-diphtheria antitoxic IgGs (80 mcg/ml), a conjugate of the horseradish peroxidase enzyme with rabbit antibodies against human IgGs, a concentrate of the phosphate buffered saline with the detergent Tween-20, a tetramethylbenzidine solution, a stop reagent, and instructions.
EFFECT: invention increases specificity, sensitivity and reproducibility of results. It also reduces analysis time.
2 cl, 2 tbl, 3 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING INDICATIONS FOR DIPHTHERIA PROPHYLACTIC IMMUNISATION | 2009 |
|
RU2414713C1 |
METHOD OF ANTIBODIES TEST TO CAPSULAR POLYSACCHARIDE Haemophillus influenzae TYPE b | 2006 |
|
RU2331075C2 |
METHOD FOR ESTIMATION OF EFFECIENCY OF VACCINATION AGAINST PERTUSSIS, DIPHTHERIA AND TETANUS | 2016 |
|
RU2626679C1 |
METHOD FOR SEROLOGICAL ASSESSMENT OF Bordetella pertussis ANATOXIN TOXICITY | 2012 |
|
RU2514011C2 |
KIT OF REAGENTS FOR IMMUNE-ENZYME ASSAY OF ENDOGENOUS BIOREGULATOR ANTIBODIES IN BLOOD SERUM FOR DETECTING ADDICTION DISORDERS | 2011 |
|
RU2495433C2 |
DRUG ADDICTION-REVEALING DIAGNOSTIC REAGENT KIT "NARCO-IFA-PEPTIDE TEST" | 2005 |
|
RU2297634C2 |
METHOD OF DETECTING ANTIBODIES IN SOLID-PHASE IMMUNOENZYMATIC ASSAY | 0 |
|
SU1645898A1 |
MOSAIC RECOMBINANT POLYPEPTIDE CONTAINING FRAGMENTS OF HEPATITIS E VIRUS PROTEINS OF GENOTYPES 1 AND 3 IN ONE POLYPEPTIDE CHAIN, INTENDED FOR USE IN TEST SYSTEMS USED IN THE SERODIAGNOSIS OF HEPATITIS E | 2020 |
|
RU2754791C1 |
STRAIN OF CULTIVATED HYBRID ANIMAL CELLS MUS MUSCULUS LINNAEUS EN-4E4 - PRODUCER OF MONOCLONAL ANTIBODIES AGAINST HUMAN ENDOGLIN (CD105) | 2015 |
|
RU2604192C1 |
CULTIVATED HYBRID ANIMAL CELLS OF MUS MUSCULUS L.-EN-4C9 - PRODUCER OF MONOCLONAL ANTIBODIES AGAINST ENDOGLIN (CD105) | 2015 |
|
RU2607029C1 |
Authors
Dates
2021-03-11—Published
2020-09-24—Filed